Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis

BACKGROUND: Metastatic melanoma patients can have durable responses to systemic therapy and even long-term survival. However, a large subgroup of patients does not benefit. Tumour metabolic alterations may well be involved in the efficacy of both targeted and immunotherapy. Knowledge on in vivo tumo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:EJNMMI Res
Asıl Yazarlar: de Heer, Ellen C., Brouwers, Adrienne H., Boellaard, Ronald, Sluiter, Wim J., Diercks, Gilles F. H., Hospers, Geke A. P., de Vries, Elisabeth G. E., Jalving, Mathilde
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Berlin Heidelberg 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6246760/
https://ncbi.nlm.nih.gov/pubmed/30460579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-018-0453-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller